BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16413395)

  • 1. A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
    McCarty JM; Melone PD; Simanis JP; Kanamori D; Dessypris EN; Warshamana-Greene GS
    Exp Hematol; 2006 Jan; 34(1):87-96. PubMed ID: 16413395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
    Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
    Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
    Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
    Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
    Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
    Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J; Sabath DF; Kuter DJ
    Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
    Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
    Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
    Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
    J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anagrelide represses GATA-1 and FOG-1 expression without interfering with thrombopoietin receptor signal transduction.
    Ahluwalia M; Donovan H; Singh N; Butcher L; Erusalimsky JD
    J Thromb Haemost; 2010 Oct; 8(10):2252-61. PubMed ID: 20586925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
    Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
    Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
    Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
    Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD
    FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells.
    Nagata Y; Nagahisa H; Aida Y; Okutomi K; Nagasawa T; Todokoro K
    J Biol Chem; 1995 Aug; 270(34):19673-5. PubMed ID: 7649975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for thrombopoietin in hemangioblast development.
    Perlingeiro RC; Kyba M; Bodie S; Daley GQ
    Stem Cells; 2003; 21(3):272-80. PubMed ID: 12743322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.
    Hong Y; Dumènil D; van der Loo B; Goncalves F; Vainchenker W; Erusalimsky JD
    Blood; 1998 Feb; 91(3):813-22. PubMed ID: 9446641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.